Contact Information:

Media Contact

Bruce Goldman

Twitter: sumedicine

Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości. - Press Release Distribution
RSS - Press News Release
Add Press Release

Drug prevents type 1 diabetes in mice, Stanford study finds

( The buildup of a substance in the pancreas during the pre-symptomatic stage of Type 1 diabetes is essential to the development of the disease, Stanford University School of Medicine researchers have shown.

The investigators used a drug to block production of this substance in mouse models, staving off damage to insulin-producing cells and preventing the onset of the autoimmune disorder. The drug, which is currently used in Europe and Asia for treating gallstone-related spasms, has an excellent safety record, the researchers said.

The findings, described in a study to be published online Sept. 14 in the Journal of Clinical Investigation, suggest that it may be possible to prevent the onset of Type 1 diabetes in humans if a similar treatment is initiated before the insulin-producing cells, or beta cells, are attacked by misguided immune cells. Type 1 diabetes, formerly called juvenile diabetes, afflicts one in 300 people in the United States.

The study is the first to link the progression of Type 1 diabetes to changes in the architecture of the extracellular matrix, the carbohydrate- and protein-rich lattice in which the cells composing our tissues are embedded, said Paul Bollyky, MD, PhD, assistant professor of infectious diseases. Bollyky is the study's senior author. The lead author is postdoctoral scholar Nadine Nagy, PhD.

Most pancreatic cells are engaged in manufacturing and secreting digestive enzymes. But the pancreas is also studded with tiny, hormone-producing cell clusters called islets. A human pancreas contains thousands of islets, scattered throughout the organ like raisins in a loaf of cinnamon bread.

Inflamed islets

A pancreatic islet is composed of several cell types, each making a different hormone. Beta cells, for example, produce insulin.

"In Type 1 diabetes, only the beta cells get destroyed," said Bollyky. Why this happens is poorly understood. But it's known that during the disorder's early, pre-symptomatic stage, pancreatic islets become inflamed -- that is, they get infiltrated by immune cells. At first quiescent, these warrior cells at some point begin attacking beta cells, eventually destroying enough of them to effectively erase insulin output. By the time a person begins to manifest the disease's hallmark symptom, chronic hyperglycemia, some 90 percent of pancreatic beta cells have been killed off. Neither the cause of immune cells' initial infiltration of pancreatic islets nor the trigger for their transition from mere passive presence to active aggression is yet understood.

But the new study provides important clues.

In a 2014 study, Bollyky's team measured the levels of dozens of substances in the extracellular matrix of human postmortem pancreatic tissue. One substance, called hyaluronan, was overly abundant near the pancreatic beta cells of people with Type 1 diabetes. But this was seen only in pancreatic tissue from patients who had been somewhat recently diagnosed, not patients who'd lived with the disease for decades.

Hyaluronan is usually present at trace concentrations in the extracellular matrix that pervades all tissues. But hyaluronan levels spike markedly at the site of an injury. "If you twist your ankle or stub your toe, that swelling you see afterwards is due to hyaluronan," Bollyky said. This substance is prone to soaking up water, causing fluid buildup in the injured region, a cardinal feature of inflammation.

Bollyky said the absence of increased hyaluronan in long-term patients' pancreatic islets didn't mean much, as these people's beta cells had long since bit the dust. But finding excessive deposits of hyaluronan near pancreatic beta cells in recent-onset cases was intriguing.

Curious, Bollyky and his colleagues sought to determine whether this association was incidental or whether hyaluronan's increased presence actually played any causal role. So, they employed a bioengineered strain of laboratory mouse whose immune system is guaranteed to attack its pancreatic beta cells. Essentially 100 percent of these mice eventually develop Type 1 diabetes, and always over about the same period of time, making it easy to study the effects of an experimental manipulation upon the disease's progression.

The scientists also looked at another mouse strain often afflicted with a version of Type 1 diabetes that more closely parallels the human form of the disease. (These mice are tougher to study because only about half of them contract the disease, and they do so at variable rates.)

In both strains, Bollyky said, hyaluronan accumulated in pancreatic islets, but not in all of them -- just in those where inflammatory immune cells had parked themselves. No excessive hyaluronan deposition was seen in the mice's heart, lung or liver tissue, consistent with the idea that the phenomenon occurs only in inflamed tissues. The islet-associated hyaluronan buildup eventually crescendoed and began tapering off, analogous to the investigators' observations in recent-onset versus long-established Type 1 diabetes cases in their earlier study of human tissue.

Preventing hyaluronan buildup

"We wondered what would happen if we prevented that buildup," Bollyky said. "And we knew a drug that does that." The drug was hymecromone, or 4-methylumbelliferone (4-MU for short). Prescribed in many European and Asian countries for painful, gallstone-associated spasms and sold by about 60 companies worldwide for research purposes, 4-MU inhibits hyaluronan synthesis. It is inexpensive, can be given orally and, over four decades of use, has what Bollyky described as an "extremely boring safety profile": a very low rate of associated adverse events. "It's even approved in Europe for kids," he said. (The Food and Drug Administration has not licensed 4-MU for any indication in the United States.)

In the mice used in the study, as in people, there's a window of time during which immune cells have infiltrated pancreatic islets but most beta cells are still intact. When the researchers initiated 4-MU treatment before the majority of the mice's beta cells had been wiped out, none of the mice developed hyperglycemia. Mice that didn't get 4-MU did. If mice stayed on a 4-MU regimen, they remained diabetes-free for at least a year. But if the regimen was stopped, they quickly became diabetic.

Tissue analysis revealed the continued presence of immune cells situated close to beta cells even in mice getting 4-MU, but the beta cells themselves seemed normal; the immune cells had evidently refrained from attacking them. The scientists also found reduced hyaluronan levels in 4-MU-treated mice's pancreatic islets, indicating that the drug was performing as expected.

Further experiments in the mice showed that hyaluronan prevents the induction of a class of regulatory immune cells, known as Tregs, whose job is to rein in their aggressive fellow immune cells and keep them from damaging healthy tissue. Bollyky likened Tregs' function to that of military police. In the absence of appropriate supervision, immune cells can get trigger-happy, he said. But by impeding hyaluronan synthesis, 4-MU re-establishes the induction of enough Tregs to prevent beta-cell destruction.

No drug has previously been shown to do this in humans, Bollyky said. His group has received preliminary funding from SPARK, a Stanford-based program devoted to fostering drug-development entrepreneurship, and is working with the FDA in preparation for a clinical trial of 4-MU for preventing Type 1 diabetes. The Stanford Office of Technology Licensing has applied for a use patent on associated intellectual property.


The study was performed in collaboration with scientists at the Benaroya Research Institute under the direction of matrix biologist Thomas Wight, PhD, whose group Bollyky was associated with when the work began. Funding for the study came from the Juvenile Diabetes Research Foundation and the National Institutes of Health (grants R01DK096087-01, R01HL113294 and U01AI101984).

Other Stanford-affiliated co-authors are postdoctoral scholar Vivekananda Sunkari, PhD, and basic life science research associates Gernot Kaber, PhD, and Hedwich Kuipers, PhD.

Stanford's Department of Medicine also supported the work.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit The medical school is part of Stanford Medicine, which includes Stanford Health Care and Lucile Packard Children's Hospital Stanford. For information about all three, please visit

Print media contact: Bruce Goldman at (650) 725-2106 (
Broadcast media contact: Margarita Gallardo at (650) 723-7897 (


Blacks in all socioeconomic groups have poorer outcomes after heart attack

DALLAS, Sept. 14, 2015 -- Black patients and patients with low socioeconomic status have shorter life expectancies after a heart attack. However, the largest racial differences in life expectancy after a heart attack occur in patients with high socioeconomic status, according to research in the American Heart Association journal Circulation. "Race and socioeconomic status are intimately related, with black individuals bearing a disproportionate burden of the poverty and health inequalities in the U.S.," said Emily Bucholz, M.D., MPH, Ph.D., lead author of the study and ...

Globalization is not saving developing countries from inequality

The processes of globalization should have contributed to reduced inequality in the world. In reality, however, the situation looks differently, with income inequality in the populations of developing economies growing. To correct this, the level of education of low-skilled workers must be increased, said Eric Maskin, Chief Research Fellow at the HSE International Laboratory of Decision Choice and Analysis and Nobel Laureate in Economics for 2007. In the last 20 years, the world has experienced unprecedented growth in global markets. Trading borders between countries ...

Building the electron superhighway

Building the electron superhighway
TV screens that roll up. Roofing tiles that double as solar panels. Sun-powered cell phone chargers woven into the fabric of backpacks. A new generation of organic semiconductors may allow these kinds of flexible electronics to be manufactured at low cost, says University of Vermont physicist and materials scientist Madalina Furis. But the basic science of how to get electrons to move quickly and easily in these organic materials remains murky. To help, Furis and a team of UVM materials scientists have invented a new way to create what they are calling "an electron ...

Learning is not a spectator sport

Free - or very inexpensive - online courses have become quite a trend in education. Massive Open Online Course (MOOC) providers currently offer thousands of courses and have enticed millions of students to enroll. The emphasis in MOOCs is often on lecture videos that students watch and learn from. However, a study published in the Proceedings of the Second (2015) ACM Conference on Learning @ Scale shows that this central approach of MOOCs - having students watch to learn - is ineffective. Instead, the emphasis on interactive activities as advocated by Carnegie Mellon ...

Queen's researcher finds evidence of emotional 'load sharing' in close relationships

KINGSTON - New research out of Queen's University has found evidence of emotional load sharing between partners in a close relationship. The study, co-authored by PhD candidate Jessica Lougheed, found that a strong relationship with a loved one can help ease stress when placed in difficult situations. "We wanted to test a new evolutionary theory in psychology called Social Baseline Theory which suggests that humans adapted to be close to other humans," says Ms. Lougheed. "The idea is that individuals function at a relative deficit when they are farther away from people ...

Upslope migration of tropical plants due to climate change

Upslope migration of tropical plants due to climate change
This news release is available in Spanish. The plants on the highest mountain in Ecuador have migrated more than 500 meters to higher altitudes during the last two centuries. This is determined in a new study, in which Aarhus University researchers compared Humboldt's data from 1802 with current conditions. Although most of the world's species diversity is found in tropical areas, there are very few studies that have examined whether tropical mountain species are affected by climate change to the same extent as temperate species. A new study has now determined ...

Molecule made by muscle shown for first time to build bone

A recently identified molecule produced by skeletal muscle in response to exercise, has been shown to increase bone mass, according to a collaborative study between researchers at the Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, the Department of Experimental and Clinical Medicine at University of Ancona in Italy, and the Department of Basic Medical Science, Neuroscience and Sense Organs at the University of Bari in Italy, and published online today in the Proceedings of the National Academy of Sciences (PNAS). Although exercise is a well known ...

Penn Vet team identifies a form of congenital night blindness in dogs

Penn Vet team identifies a form of congenital night blindness in dogs
People with congenital stationary night blindness, or CSNB, have normal vision during the day but find it difficult or impossible to distinguish objects in low light. This rare condition is present from birth and can seriously impact quality of life, especially in locations and conditions where artificial illumination is not available. Working in collaboration with Japanese scientists, researchers at the University of Pennsylvania have for the first time found a form of CSNB in dogs. Their discovery and subsequent hunt for the genetic mutation responsible may one day ...

Loss of cellular energy leads to neuronal dysfunction in neurodegenerative disease model

A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria--the brain's cellular power plants--can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease. A link between mitochondria, energy failure, and neurodegeneration has long been hypothesized. However, no previous studies were able to comprehensively investigate the connection because sufficiently sensitive tests, or assays, were not available to measure ATP (the energy unit of the cell that is generated by mitochondria) in individual ...

GW participates in landmark study; blood pressure management can reduce heart disease death

WASHINGTON (Sept. 14, 2015) -- According to initial results of a multi-site landmark study, led by Dominic Raj, M.D., at the George Washington University (GW) site, cardiovascular disease morbidity is significantly reduced through intensive management of high blood pressure. By targeting a blood pressure of 120 millimeters of mercury (mm Hg), lower than current guidelines, researchers found that adults 50 years and older also significantly reduced their rates of cardiovascular disease and cardiovascular events, such as heart attack and heart failure, as well as stroke, ...


How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[] Drug prevents type 1 diabetes in mice, Stanford study finds is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.